BBF Healthcare Program in 2021
Article by Liam Carstens
In 2021, the team at BBF has remained focused on increasing donations of pharmaceuticals. Through introductions and follow-ups by BBF Trustee Lance Kann as well as research and outreach by BBF Program Coordinator, Abigael Siecinski, we added five new pharmaceutical donors in 2021: Glenmark, Nephron, Macleods, Tris, and Lupin. Additionally, BBF Trustee Chronis Manolis provided a needed reintroduction to Sun Pharmaceuticals, a past donor who began donating again in December 2021.
As a result of these generous efforts, BBF received substantial donations of more than 3.2 million units of medicine (bottles, suspensions, tubes, bags, etc.). These equate to more than 203 million doses of sorely needed medicines like antibiotics, antifungals, and antivirals as well as medications for the management of chronic conditions like diabetes and heart disease. As in years past, Teva and Viatris (formerly Mylan) remain our largest contributors and we are extremely thankful for both their support and that of all of our kind donors.
These incredible numbers made 2021 an excellent year for BBF’s Healthcare Program. BBF sent the equivalent of 105 ocean-going containers of pharmaceuticals, supplies, and medical equipment to recipients in 18 different countries. These shipments, valued at over $117 million, consisted of requested items for hospitals, health centers, and clinics in Guatemala, Honduras, El Salvador, Nicaragua, Haiti, Dominican Republic, Jamaica, Trinidad and Tobago, Saint Vincent, Grenada, Malawi, Sierra Leone, Zimbabwe, Mozambique, Burundi, Kenya, Pakistan, Lebanon, Venezuela, and to partners in the United States.